{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T07:45:29Z","timestamp":1784015129151,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-01051-6","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T10:17:55Z","timestamp":1764325075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology of drug-related liver injury among the elderly: a systematic review and meta-analysis of incidence, and risk factors"],"prefix":"10.1186","volume":"27","author":[{"given":"Yujing","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"6","key":"1051_CR1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"EASL Clinical Practice Guidelines","year":"2019","unstructured":"EASL Clinical Practice Guidelines. Drug-induced liver injury. J Hepatol. 2019;70(6):1222\u201361.","journal-title":"J Hepatol"},{"issue":"9","key":"1051_CR2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/liv.15262","volume":"42","author":"X Li","year":"2022","unstructured":"Li X, Tang J, Mao Y. Incidence and risk factors of drug-induced liver injury. Liver Int. 2022;42(9):1999\u20132014.","journal-title":"Liver Int"},{"issue":"8","key":"1051_CR3","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","volume":"156","author":"T Shen","year":"2019","unstructured":"Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, Xu J, Niu J, Liu J, Watkins PB, et al. Incidence and etiology of Drug-Induced liver injury in Mainland China. Gastroenterology. 2019;156(8):2230\u2013e22412211.","journal-title":"Gastroenterology"},{"issue":"5","key":"1051_CR4","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14309\/ajg.0000000000001259","volume":"116","author":"NP Chalasani","year":"2021","unstructured":"Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR. ACG clinical guideline: diagnosis and management of idiosyncratic Drug-Induced liver injury. Am J Gastroenterol. 2021;116(5):878\u201398.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1051_CR5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12072-021-10144-3","volume":"15","author":"H Devarbhavi","year":"2021","unstructured":"Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, et al. Drug-induced liver injury: Asia Pacific association of study of liver consensus guidelines. Hepatol Int. 2021;15(2):258\u201382.","journal-title":"Hepatol Int"},{"key":"1051_CR6","unstructured":"Standard WW-. Standard Populations. SEER Datasets, https:\/\/seer.cancer.gov\/stdpopulations\/world.who.html."},{"issue":"3","key":"1051_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000052829","volume":"48","author":"J Zeeh","year":"2002","unstructured":"Zeeh J, Platt D. The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology. 2002;48(3):121\u20137.","journal-title":"Gerontology"},{"issue":"4","key":"1051_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11894-021-00804-7","volume":"23","author":"BT Lee","year":"2021","unstructured":"Lee BT, Odin JA, Grewal P. An approach to Drug-Induced liver injury from the geriatric perspective. Curr Gastroenterol Rep. 2021;23(4):6.","journal-title":"Curr Gastroenterol Rep"},{"issue":"9967","key":"1051_CR9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(14)61347-7","volume":"385","author":"MJ Prince","year":"2015","unstructured":"Prince MJ, Wu F, Guo Y, Gutierrez Robledo LM, O\u2019Donnell M, Sullivan R, Yusuf S. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385(9967):549\u201362.","journal-title":"Lancet"},{"issue":"6","key":"1051_CR10","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","volume":"135","author":"N Chalasani","year":"2008","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the united States. Gastroenterology. 2008;135(6):1924\u201334. 1934.e1921-1924.","journal-title":"Gastroenterology"},{"issue":"2","key":"1051_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","volume":"42","author":"E Bj\u00f6rnsson","year":"2005","unstructured":"Bj\u00f6rnsson E, Olsson R. Outcome and prognostic markers in severe drug-induced liver disease. Hepatology. 2005;42(2):481\u20139.","journal-title":"Hepatology"},{"issue":"2","key":"1051_CR12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","volume":"129","author":"RJ Andrade","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fern\u00e1ndez MC, Pelaez G, Pachkoria K, Garc\u00eda-Ruiz E, Garc\u00eda-Mu\u00f1oz B, Gonz\u00e1lez-Grande R, Pizarro A, Dur\u00e1n JA, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512\u201321.","journal-title":"Gastroenterology"},{"issue":"4","key":"1051_CR13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.21324","volume":"44","author":"MI Lucena","year":"2006","unstructured":"Lucena MI, Andrade RJ, Fern\u00e1ndez MC, Pachkoria K, Pelaez G, Dur\u00e1n JA, Villar M, Rodrigo L, Romero-Gomez M, Planas R, et al. Determinants of the clinical expression of amoxicillin\u2010clavulanate hepatotoxicity. Hepatology. 2006;44(4):850\u20136.","journal-title":"Hepatology"},{"issue":"6","key":"1051_CR14","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","volume":"49","author":"MI Lucena","year":"2009","unstructured":"Lucena MI, Andrade RJ, Kaplowitz N, Garcia-Cortes M, Fernandez MC, Romero-Gomez M, Bruguera M, Hallal H, Robles-Diaz M, Rodriguez-Gonzalez JF, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49(6):2001\u20139.","journal-title":"Hepatology"},{"issue":"4","key":"1051_CR15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/cpt.2108","volume":"109","author":"RA Weersink","year":"2021","unstructured":"Weersink RA, Alvarez-Alvarez I, Medina-C\u00e1liz I, Sanabria-Cabrera J, Robles-D\u00edaz M, Ortega-Alonso A, Garc\u00eda-Cort\u00e9s M, Bonilla E, Niu H, Soriano G, et al. Clinical characteristics and outcome of Drug-Induced liver injury in the older patients: from the Young-Old to the Oldest-Old. Clin Pharmacol Ther. 2021;109(4):1147\u201358.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"1051_CR16","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","volume":"144","author":"ES Bj\u00f6rnsson","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419\u201325. 1425.e1411-1413; quiz e1419-1420.","journal-title":"Gastroenterology"},{"key":"1051_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.maturitas.2020.05.018","volume":"139","author":"E Rudnicka","year":"2020","unstructured":"Rudnicka E, Napiera\u0142a P, Podfigurna A, M\u0119czekalski B, Smolarczyk R, Grymowicz M. The world health organization (WHO) approach to healthy ageing. Maturitas. 2020;139:6\u201311.","journal-title":"Maturitas"},{"issue":"2","key":"1051_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67\u201376.","journal-title":"Drug Metab Rev"},{"issue":"6","key":"1051_CR19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806\u201315.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1051_CR20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/pst.2068","volume":"20","author":"C Luchini","year":"2021","unstructured":"Luchini C, Veronese N, Nottegar A, Shin JI, Gentile G, Granziol U, Soysal P, Alexinschi O, Smith L, Solmi M. Assessing the quality of studies in meta-research: Review\/guidelines on the most important quality assessment tools. Pharm Stat. 2021;20(1):185\u201395.","journal-title":"Pharm Stat"},{"issue":"9","key":"1051_CR21","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","volume":"107","author":"KT Suk","year":"2012","unstructured":"Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS, Baik GH, Kim JB, Kweon YO, Kim BI, et al. A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol. 2012;107(9):1380\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1051_CR22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1478-3231.2007.01461.x","volume":"27","author":"CT Wai","year":"2007","unstructured":"Wai CT, Tan BH, Chan CL, Sutedja DS, Lee YM, Khor C, Lim SG. Drug-induced liver injury at an Asian center: a prospective study. Liver Int. 2007;27(4):465\u201374.","journal-title":"Liver Int"},{"issue":"8","key":"1051_CR23","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","volume":"24","author":"MB De Valle","year":"2006","unstructured":"De Valle MB, Av Klinteberg V, Alem N, Olsson R, Bj\u00f6rnsson E. Drug-induced liver injury in a Swedish university hospital out-patient hepatology clinic. Aliment Pharmacol Ther. 2006;24(8):1187\u201395.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"1051_CR24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0168-8278(02)00231-3","volume":"37","author":"L Ib\u00e1\u00f1ez","year":"2002","unstructured":"Ib\u00e1\u00f1ez L, P\u00e9rez E, Vidal X, Laporte JR. Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs. J Hepatol. 2002;37(5):592\u2013600.","journal-title":"J Hepatol"},{"issue":"7","key":"1051_CR25","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s10620-008-0250-x","volume":"53","author":"EJ Carey","year":"2008","unstructured":"Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, Rakela J. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci. 2008;53(7):1977\u201382.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1051_CR26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.meg.0000250581.77865.68","volume":"19","author":"SH Hussaini","year":"2007","unstructured":"Hussaini SH, O\u2019Brien CS, Despott EJ, Dalton HR. Antibiotic therapy: a major cause of drug-induced jaundice in Southwest England. Eur J Gastroenterol Hepatol. 2007;19(1):15\u201320.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"1051_CR27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00228-004-0888-z","volume":"61","author":"Y Meier","year":"2005","unstructured":"Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, Fattinger K. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61(2):135\u201343.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"1051_CR28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2036.2007.03338.x","volume":"25","author":"M Sabat\u00e9","year":"2007","unstructured":"Sabat\u00e9 M, Ib\u00e1\u00f1ez L, P\u00e9rez E, Vidal X, Buti M, Xiol X, Mas A, Guarner C, Forn\u00e9 M, Sol\u00e0 R, et al. Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther. 2007;25(12):1401\u20139.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"1051_CR29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jcpt.12039","volume":"38","author":"M Sistanizad","year":"2013","unstructured":"Sistanizad M, Peterson GM. Drug-induced liver injury in the Australian setting. J Clin Pharm Ther. 2013;38(2):115\u201320.","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"1051_CR30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cgh.2017.12.051","volume":"16","author":"I Medina-Caliz","year":"2018","unstructured":"Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A, Cabello MR, Robles-Diaz M, Sanabria-Cabrera J, Sanjuan-Jimenez R, Ortega-Alonso A, Garc\u00eda-Mu\u00f1oz B, Moreno I, et al. Herbal and dietary Supplement-Induced liver injuries in the Spanish DILI registry. Clin Gastroenterol Hepatol. 2018;16(9):1495\u2013502.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1051_CR31","first-page":"160","volume":"130","author":"LX Yang","year":"2017","unstructured":"Yang LX, Liu CY, Zhang LL, Lai LL, Fang M, Zhang C. Clinical characteristics of patients with Drug-induced liver injury. Chin Med J (Engl). 2017;130(2):160\u20134.","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"1051_CR32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.21037\/atm-20-5144","volume":"9","author":"JH Park","year":"2021","unstructured":"Park JH, Hong S, Jun DW, Yoon JH, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS. Prevalence and clinical characteristics of antibiotics associated drug induced liver injury. Ann Transl Med. 2021;9(8):642.","journal-title":"Ann Transl Med"},{"issue":"8","key":"1051_CR34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.clinthera.2024.04.014","volume":"46","author":"X Ma","year":"2024","unstructured":"Ma X, Chen Z, An J, Zhang C. Clinical features and risk factors for Drug-Induced liver injury: A retrospective study from China. Clin Ther. 2024;46(8):597\u2013603.","journal-title":"Clin Ther"},{"issue":"5","key":"1051_CR35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/1751-2980.13205","volume":"24","author":"M Li","year":"2023","unstructured":"Li M, Wang Y, Lv TT, Liu JM, Kong YY, Jia JD, Zhao XY. Mapping the incidence of drug-induced liver injury: A systematic review and meta-analysis. J Dig Dis. 2023;24(5):332\u20139.","journal-title":"J Dig Dis"},{"issue":"1","key":"1051_CR36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12877-021-02512-3","volume":"21","author":"T Chinzowu","year":"2021","unstructured":"Chinzowu T, Roy S, Nishtala PS. Risk of antimicrobial-associated organ injury among the older adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):617.","journal-title":"BMC Geriatr"},{"issue":"2","key":"1051_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjopharm.2012.02.003","volume":"10","author":"F Mizokami","year":"2012","unstructured":"Mizokami F, Koide Y, Noro T, Furuta K. Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother. 2012;10(2):123\u20138.","journal-title":"Am J Geriatr Pharmacother"},{"key":"1051_CR38","doi-asserted-by":"crossref","unstructured":"Qu L, Jiao B. The interplay between immune and metabolic pathways in kidney disease. Cells 2023, 12(12).","DOI":"10.3390\/cells12121584"},{"issue":"10","key":"1051_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2024.0388","volume":"85","author":"HJ Woodford","year":"2024","unstructured":"Woodford HJ. Polypharmacy in older patients. Br J Hosp Med (Lond). 2024;85(10):1\u201312.","journal-title":"Br J Hosp Med (Lond)"},{"issue":"4","key":"1051_CR40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tem.2009.01.005","volume":"20","author":"NA Timchenko","year":"2009","unstructured":"Timchenko NA. Aging and liver regeneration. Trends Endocrinol Metab. 2009;20(4):171\u20136.","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"1051_CR41","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2013.05.027","volume":"153","author":"HC Chang","year":"2013","unstructured":"Chang HC, Guarente L. SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell. 2013;153(7):1448\u201360.","journal-title":"Cell"},{"issue":"12","key":"1051_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0181-3","volume":"50","author":"Y Xiao","year":"2018","unstructured":"Xiao Y, Zhou K, Lu Y, Yan W, Cai W, Wang Y. Administration of antibiotics contributes to cholestasis in pediatric patients with intestinal failure via the alteration of FXR signaling. Exp Mol Med. 2018;50(12):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"12","key":"1051_CR43","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1172\/JCI128289","volume":"129","author":"S Win","year":"2019","unstructured":"Win S, Min RW, Chen CQ, Zhang J, Chen Y, Li M, Suzuki A, Abdelmalek MF, Wang Y, Aghajan M, et al. Expression of mitochondrial membrane-linked SAB determines severity of sex-dependent acute liver injury. J Clin Invest. 2019;129(12):5278\u201393.","journal-title":"J Clin Invest"},{"key":"1051_CR44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.biocel.2015.01.009","volume":"60","author":"C Piperi","year":"2015","unstructured":"Piperi C, Goumenos A, Adamopoulos C, Papavassiliou AG. AGE\/RAGE signalling regulation by mirnas: associations with diabetic complications and therapeutic potential. Int J Biochem Cell Biol. 2015;60:197\u2013201.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"1051_CR45","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.crohns.2012.09.001","volume":"7","author":"EI Benchimol","year":"2013","unstructured":"Benchimol EI, Cook SF, Erichsen R, Long MD, Bernstein CN, Wong J, Carroll CF, Fr\u00f8slev T, Sampson T, Kappelman MD. International variation in medication prescription rates among elderly patients with inflammatory bowel disease. J Crohns Colitis. 2013;7(11):878\u201389.","journal-title":"J Crohns Colitis"},{"key":"1051_CR46","doi-asserted-by":"crossref","first-page":"1001263","DOI":"10.3389\/fimmu.2022.1001263","volume":"13","author":"W Shen","year":"2022","unstructured":"Shen W, Liu S, Ou L. rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis. Front Immunol. 2022;13:1001263.","journal-title":"Front Immunol"},{"issue":"32","key":"1051_CR47","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.3748\/wjg.v27.i32.5376","volume":"27","author":"D Remash","year":"2021","unstructured":"Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol. 2021;27(32):5376\u201391.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1051_CR48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/gerona\/glx126","volume":"73","author":"U Vespasiani-Gentilucci","year":"2018","unstructured":"Vespasiani-Gentilucci U, De Vincentis A, Ferrucci L, Bandinelli S, Antonelli Incalzi R, Picardi A. Low Alanine aminotransferase levels in the elderly population: Frailty, Disability, Sarcopenia, and reduced survival. J Gerontol Biol Sci Med Sci. 2018;73(7):925\u201330.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"1","key":"1051_CR49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261\u201383.","journal-title":"Hepatology"},{"issue":"9","key":"1051_CR50","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.14309\/ajg.0000000000001836","volume":"117","author":"PH Hayashi","year":"2022","unstructured":"Hayashi PH, Lucena MI, Fontana RJ. RECAM: A new and Improved, computerized causality assessment tool for DILI diagnosis. Am J Gastroenterol. 2022;117(9):1387\u20139.","journal-title":"Am J Gastroenterol"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-01051-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-01051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:03:36Z","timestamp":1767463416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40360-025-01051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-01051-6","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors, and therefore ethics committee approval is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}